Congenital IGF1 deficiency tends to confer protection against post-natal development of malignancies.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  European Journal of Endocrinology

• Publication date

  2011-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1530/EJE-10-0859PMID 21292919
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• 182 – Approach to the Patient with Cancer

  2012cited by this paper
• Ewing's sarcoma.

  2010cited by this paper
• Initial testing of a monoclonal antibody (IMC‐A12) against IGF‐1R by the pediatric preclinical testing program

  2010cited by this paper
• Longevity in untreated congenital growth hormone deficiency due to a homozygous mutation in the GHRH receptor gene.

  2010cited by this paper
• Targeting insulin-like growth factor type 1 receptor in cancer therapy

  2009cited by this paper
• The nomenclature of neonatal size--a conundrum.

  2009cited by this paper
• Growth Hormone Modulates Migration of Developing T Cells

  2009cited by this paper
• Reduced incidence and delayed occurrence of fatal neoplastic diseases in growth hormone receptor/binding protein knockout mice.

  2009cited by this paper
• For debate: the pathophysiological significance of IGF-I receptor overexpression: new insights.

  2009cited by this paper
• The Pathophysiological Significance of IGF-I Receptor Overexpression: New Insights

  2009cited by this paper
• Neuroendocrine inhibition of glucose production and resistance to cancer in dwarf mice.

  2009cited by this paper
• Autocrine human growth hormone stimulates oncogenicity of endometrial carcinoma cells.

  2008cited by this paper
• The role of insulin receptors and IGF-I receptors in cancer and other diseases

  2008cited by this paper
• Patients with congenital deficiency of IGF-I seem protected from the development of malignancies: a preliminary report.

  2007cited by this paper
• Blastemal expression of type I insulin-like growth factor receptor in Wilms' tumors is driven by increased copy number and correlates with relapse.

  2006cited by this paper
• Disruption of growth hormone signaling retards early stages of prostate carcinogenesis in the C3(1)/T antigen mouse.

  2005cited by this paper
• Insulin-like growth factors and neoplasia

  2004cited by this paper
• Delayed occurrence of fatal neoplastic diseases in ames dwarf mice: correlation to extended longevity.

  2003cited by this paper
• Insulin-like growth factors and cancer.

  2002cited by this paper
• Growth hormone-deficient dwarf animals are resistant to dimethylbenzanthracine (DMBA)-induced mammary carcinogenesis.

  2002cited by this paper
• Journals of Gerontology

  2001cited by this paper
• Is the Laron mouse an accurate model of Laron syndrome?

  1999cited by this paper
• A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse).

  1997cited by this paper
• The insulin-like growth factor-I receptor signaling pathways are important for tumorigenesis and inhibition of apoptosis.

  1997cited by this paper
• Insulin-like Growth Factors and Cancer

  1995cited by this paper
• Up-regulation of insulin-like growth factor-I (IGF-I) receptor gene expression in patients with reduced serum IGF-I levels.

  1993cited by this paper
• BMDP statistical software

  1983cited by this paper
• Approach to the patient with cancer.

  1981cited by this paper
• EWING'S SARCOMA.

  1964cited by this paper

• Protein-Restricted Diets and Their Impact on Metabolic Health and Aging.

  2025cites this paper
• Precision medicine, insulin-like growth factors and cancer therapy

  2025cites this paper
• Growth hormone replacement therapy in childhood-onset craniopharyngioma.

  2025cites this paper
• Increased cancer risk in a cohort of patients with acromegaly in Israel.

  2025cites this paper
• Disabilities and Handicaps of Patients with Laron Syndrome

  2025cites this paper
• Nutrition, GH/IGF-I signaling, and cancer.

  2024cites this paper
• Human Aging and Age-Related Diseases: From Underlying Mechanisms to Pro-Longevity Interventions

  2024cites this paper
• Skin assessment in congenital untreated isolated GH deficiency

  2024cites this paper
• CRISPR-Cas9 mediated d3GHR knockout in HEK293 cells: Revealing the longevity associated isoform stress resilience.

  2024cites this paper
• Can the reduced GH, IGF-1, and ovarian steroids concentrations be considered as suspected biomarkers of age-associated functional deficit in mares?

  2024cites this paper
• Growth hormone insensitivity and adipose tissue: tissue morphology and transcriptome analyses in pigs and humans

  2023cites this paper
• IGF-1 and Risk of Morbidity and Mortality From Cancer, Cardiovascular Diseases, and All Causes in EPIC-Heidelberg

  2023cites this paper
• Insulin Receptor Isoforms and Insulin Growth Factor-like Receptors: Implications in Cell Signaling, Carcinogenesis, and Chemoresistance

  2023cites this paper
• Growth hormone treatment for non-GHD disorders: Excitement tempered by biology.

  2023cites this paper
• Insulin-like growth factors and aging: lessons from Laron syndrome

  2023cites this paper
• Combination of the biomarkers for aging and cancer? - Challenges and current status

  2023cites this paper
• The hallmarks of cancer metabolism: Still emerging.

  2022cites this paper
• Covert actions of growth hormone: fibrosis, cardiovascular diseases and cancer

  2022cites this paper
• The Role of Insulin-like Growth Factor-1 and Its Receptor in the Eye: A Review and Implications for IGF-1R Inhibition

  2022cites this paper
• Metabolism and cancer-select topics

  2022cites this paper
• How size and genetic diversity shape lifespan across breeds of purebred dogs

  2022cites this paper
• The endocrine and epigenetic impact of persistent cow milk consumption on prostate carcinogenesis

  2022cites this paper
• GH action in prostate cancer cells promotes proliferation limits apoptosis and regulates cancer-related gene expression.

  2022cites this paper
• Growth hormone receptor antagonism downregulates ATP-binding cassette transporters contributing to improved drug efficacy against melanoma and hepatocarcinoma in vivo

  2022cites this paper
• Decreased lifespan in female "Munchkin" actors from the cast of the 1939 film version of The Wizard of Oz does not support the hypothesis linking hypopituitary dwarfism to longevity.

  2022cites this paper
• Follow, consider, and catch: second primary tumors in acromegaly patients

  2022cites this paper
• Long-Term IGF1 Stimulation Leads to Cellular Senescence via Functional Interaction with the Thioredoxin-Interacting Protein, TXNIP

  2022cites this paper
• Association between IGF‐1 levels ranges and all‐cause mortality: A meta‐analysis

  2022cites this paper
• Conditional gene regulation models demonstrate a pro‐proliferative role for growth hormone receptor in prostate cancer

  2022cites this paper
• Mammary tumor growth and proliferation are dependent on growth hormone in female SV40 C3(1) T-antigen mice.

  2022cites this paper
• Safety of growth hormone replacement in survivors of cancer and intracranial and pituitary tumours: a consensus statement

  2022cites this paper
• Identification of UDP-Glucuronosyltransferase 2B15 (UGT2B15) as a Target for IGF1 and Insulin Action

  2022cites this paper
• Antiaging agents: safe interventions to slow aging and healthy life span extension

  2022cites this paper
• Growth hormone, not IGF-1 is the key longevity regulator in mammals.

  2022cites this paper
• MicroRNA 132-3p Is Upregulated in Laron Syndrome Patients and Controls Longevity Gene Expression

  2021cites this paper
• Safety of Pediatric rhGH Therapy: An Overview and the Need for Long-Term Surveillance

  2021cites this paper
• The Olfactory Receptor Gene Product, OR5H2, Modulates Endometrial Cancer Cells Proliferation via Interaction with the IGF1 Signaling Pathway

  2021cites this paper
• Safety of growth hormone (GH) treatment in GH deficient children and adults treated for cancer and non-malignant intracranial tumors—a review of research and clinical practice

  2021cites this paper
• Teprotumumab: interpreting the clinical trials in the context of thyroid eye disease pathogenesis and current therapies.

  2021cites this paper
• Growth Hormone Modulation of Hepatic Epidermal Growth Factor Receptor Signaling.

  2021cites this paper
• Dual Characters of GH-IGF1 Signaling Pathways in Radiotherapy and Post-radiotherapy Repair of Cancers

  2021cites this paper
• Insulin-Like Growth Factor-1 (IGF-1) and Its Monitoring in Medical Diagnostic and in Sports

  2021cites this paper
• Fellows' Forum: Benefits of living without growth hormone.

  2021cites this paper
• ZYG11A Is Expressed in Epithelial Ovarian Cancer and Correlates With Low Grade Disease

  2021cites this paper
• Mammary Tumors Growing in the Absence of Growth Hormone are More Sensitive to Doxorubicin than Wild-type Tumors.

  2021cites this paper
• Intermittent and Periodic Fasting, Hormones, and Cancer Prevention

  2021cites this paper
• Extending lifespan by modulating the growth hormone/insulin-like growth factor-1 axis: coming of age

  2021cites this paper
• The Association Between High Birth Weight and Long-Term Outcomes—Implications for Assisted Reproductive Technologies: A Systematic Review and Meta-Analysis

  2021cites this paper
• Laron syndrome – A historical perspective

  2020cites this paper
• Effect of growth hormone on insulin signaling.

  2020cites this paper
• Role of the GH-IGF1 system in progression of cancer.

  2020cites this paper
• Disruption of the GHRH receptor and its impact on children and adults: The Itabaianinha syndrome

  2020cites this paper
• Growth hormone receptor knockout: Relevance to xenotransplantation

  2020cites this paper
• Aging in Complex Multicellular Organisms

  2020cites this paper
• Volumetric Abnormalities in Violent Schizophrenia Patients on the General Psychiatric Ward

  2020cites this paper
• Changes in plasma amino acids metabolites, caused by long-term IGF-I deficiency, are reversed by IGF-I treatment - A pilot study.

  2020cites this paper
• Fasting to enhance Cancer treatment in models: the next steps

  2020cites this paper
• Growth Hormone Upregulates Mediators of Melanoma Drug Efflux and Epithelial-to-Mesenchymal Transition In Vitro and In Vivo

  2020cites this paper
• Unraveling the Resistance of IGF-Pathway Inhibition in Ewing Sarcoma

  2020cites this paper
• Identification of nephronectin as a new target for IGF1 action.

  2020cites this paper
• Associations Between Circulating Insulin-Like Growth Factor 1 and Mortality in Women With Invasive Breast Cancer

  2020cites this paper
• Laron Syndrome Research Paves the Way for New Insights in Oncological Investigation

  2020cites this paper
• Risk of cancer in patients treated with recombinant human growth hormone in childhood

  2019cites this paper
• The effects of growth hormone on therapy resistance in cancer

  2019cites this paper
• Identification of ZYG11A as a candidate IGF1-dependent proto-oncogene in endometrial cancer

  2019cites this paper
• Genome-Wide Profiling of Laron Syndrome Patients Identifies Novel Cancer Protection Pathways

  2019cites this paper
• Targeting growth hormone function: strategies and therapeutic applications

  2019cites this paper
• Investigational IGF1R inhibitors in early stage clinical trials for cancer therapy

  2019cites this paper
• Diagnosis of Laron syndrome using monoplex-polymerase chain reaction technology with a whole-genome amplification template: A case report

  2019cites this paper
• Protein Quantity and Source, Fasting-Mimicking Diets, and Longevity

  2019cites this paper
• GH "knockout" mice have increased subcutaneous adipose tissue with decreased fibrosis and enhanced insulin sensitivity.

  2019cites this paper
• IGF signalling in germ cells and testicular germ cell tumours: roles and therapeutic approaches

  2019cites this paper
• Metabolic effects and long-term safety of childhood growth hormone treatment

  2019cites this paper
• From White to Brown - Adipose Tissue Is Critical to the Extended Lifespan and Healthspan of Growth Hormone Mutant Mice.

  2019cites this paper
• Reviews on Biomarker Studies in Aging and Anti-Aging Research

  2019influential citation
• Congenital neuroblastoma in a neonate with hypoparathyroidism-retardation-dysmorphism syndrome.

  2019influential citation
• Therapeutic Targeting of the IGF Axis

  2019cites this paper
• Identification of thioredoxin-interacting protein (TXNIP) as a downstream target for IGF1 action

  2018cites this paper
• Growth hormone receptor-deficient pigs resemble the pathophysiology of human Laron syndrome and reveal altered activation of signaling cascades in the liver

  2018cites this paper
• Acne vulgaris: The metabolic syndrome of the pilosebaceous follicle.

  2018cites this paper
• Effects of growth hormone on pregnancy rates of patients with thin endometrium

  2018cites this paper
• Systemic Complications of Acromegaly and the Impact of the Current Treatment Landscape: An Update.

  2018cites this paper
• MECHANISMS IN ENDOCRINOLOGY: Lessons from growth hormone receptor gene-disrupted mice: are there benefits of endocrine defects?

  2018cites this paper
• Recombinant human growth hormone: a medical miracle or cause for concern?

  2018cites this paper
• Occurrence of neoplasms in individuals with congenital, severe GH deficiency from the Itabaianinha kindred.

  2018influential citation
• Growth Hormone's Links to Cancer.

  2018cites this paper
• Growth Hormone Deficiency: Health and Longevity.

  2018cites this paper
• A framework for selection of blood-based biomarkers for geroscience-guided clinical trials: report from the TAME Biomarkers Workgroup

  2018cites this paper
• Obesity and the Growth Hormone Axis

  2018cites this paper
• Size matters: height, cell number and a person's risk of cancer

  2018cites this paper
• Insulin-Like Growth Factor (IGF) Pathway Targeting in Cancer: Role of the IGF Axis and Opportunities for Future Combination Studies

  2017cites this paper
• eview rotective effects of short-term dietary restriction in surgical stress nd chemotherapy

  2017cites this paper
• Tumour-Derived Human Growth Hormone As a Therapeutic Target in Oncology.

  2017cites this paper
• IGF 1 and IGF 2

  2017cites this paper
• Genome-wide profiling of congenital insulin-like growth factor-1 deficient patients: translational implications in cancer preven- tion and metabolism

  2017cites this paper
• Interventions to slow cardiovascular aging: Dietary restriction, drugs and novel molecules.

  2017cites this paper
• IGF-I deficiency, longevity and cancer protection of patients with Laron syndrome.

  2017cites this paper
• Ocular findings in adult subjects with an inactivating mutation in GH releasing hormone receptor gene.

  2017cites this paper
• Fifty years on: New lessons from Laron syndrome.

  2017cites this paper
• Growth Hormone’s Effect on Adipose Tissue: Quality versus Quantity

  2017cites this paper